Cargando…
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
In China, chronic obstructive pulmonary disease (COPD) was accounted for a quarter of the global COPD population and has become a large economic burden. However, the comprehensive picture of the COPD burden, which could inform health policy, is not readily available for all of the provinces of China...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215345/ https://www.ncbi.nlm.nih.gov/pubmed/35757649 http://dx.doi.org/10.3389/fpubh.2022.859499 |
_version_ | 1784731190052257792 |
---|---|
author | Yin, Peng Wu, Jiayuan Wang, Lijun Luo, Chaole Ouyang, Lihuan Tang, Xiantong Liu, Jiangmei Liu, Yunning Qi, Jinlei Zhou, Maigeng Lai, Tianwen |
author_facet | Yin, Peng Wu, Jiayuan Wang, Lijun Luo, Chaole Ouyang, Lihuan Tang, Xiantong Liu, Jiangmei Liu, Yunning Qi, Jinlei Zhou, Maigeng Lai, Tianwen |
author_sort | Yin, Peng |
collection | PubMed |
description | In China, chronic obstructive pulmonary disease (COPD) was accounted for a quarter of the global COPD population and has become a large economic burden. However, the comprehensive picture of the COPD burden, which could inform health policy, is not readily available for all of the provinces of China. Here, we aimed to describe the burden of COPD in China, providing an up-to-date and comprehensive analysis at the national and provincial levels, and time trends from 1990 to 2019. Following the methodology framework and general analytical strategies used in the GBD 2019, we analyzed the incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years with life lost (YLLs) attributable to COPD across China and the corresponding time trends from 1990 to 2019, stratified by age and province. In order to quantify the secular trends of the burden of COPD, the estimated annual percentage changes were calculated by the linear regression model of age-standardized rates (ASRs) and calendar years. We also presented the contribution of risk factors to COPD-related mortality and DALYs. The association between COPD burden and socio-demographic index (SDI) were also evaluated. From 1990 to 2019, the incidence and prevalence numbers of COPD increased by 61.2 and 67.8%, respectively, whereas the number of deaths and DALYs owing to COPD decreased. The ASRs of COPD burden, including incidence, prevalence, mortality, DALYs, YLDs, and YLLs continuously decreased from 1990 to 2019. The crude rates of COPD burden dramatically increased with age and reached a peak in the older than 95 years age group. In 2019, the leading risk factor for COPD mortality and DALYs was tobacco use in the whole population, but ambient particulate matter pollution was the most significant risk factor in females. At the provincial level, the ASRs of COPD burden was significantly associated with the SDIs, with the highest ASRs in the western provinces with low SDIs. Collectively, our study indicated that COPD remains an important public health problem in China. Geographically targeted considerations should be developed to enhance COPD health and reduce the COPD burden throughout China and in specific provinces. |
format | Online Article Text |
id | pubmed-9215345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92153452022-06-23 The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 Yin, Peng Wu, Jiayuan Wang, Lijun Luo, Chaole Ouyang, Lihuan Tang, Xiantong Liu, Jiangmei Liu, Yunning Qi, Jinlei Zhou, Maigeng Lai, Tianwen Front Public Health Public Health In China, chronic obstructive pulmonary disease (COPD) was accounted for a quarter of the global COPD population and has become a large economic burden. However, the comprehensive picture of the COPD burden, which could inform health policy, is not readily available for all of the provinces of China. Here, we aimed to describe the burden of COPD in China, providing an up-to-date and comprehensive analysis at the national and provincial levels, and time trends from 1990 to 2019. Following the methodology framework and general analytical strategies used in the GBD 2019, we analyzed the incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years with life lost (YLLs) attributable to COPD across China and the corresponding time trends from 1990 to 2019, stratified by age and province. In order to quantify the secular trends of the burden of COPD, the estimated annual percentage changes were calculated by the linear regression model of age-standardized rates (ASRs) and calendar years. We also presented the contribution of risk factors to COPD-related mortality and DALYs. The association between COPD burden and socio-demographic index (SDI) were also evaluated. From 1990 to 2019, the incidence and prevalence numbers of COPD increased by 61.2 and 67.8%, respectively, whereas the number of deaths and DALYs owing to COPD decreased. The ASRs of COPD burden, including incidence, prevalence, mortality, DALYs, YLDs, and YLLs continuously decreased from 1990 to 2019. The crude rates of COPD burden dramatically increased with age and reached a peak in the older than 95 years age group. In 2019, the leading risk factor for COPD mortality and DALYs was tobacco use in the whole population, but ambient particulate matter pollution was the most significant risk factor in females. At the provincial level, the ASRs of COPD burden was significantly associated with the SDIs, with the highest ASRs in the western provinces with low SDIs. Collectively, our study indicated that COPD remains an important public health problem in China. Geographically targeted considerations should be developed to enhance COPD health and reduce the COPD burden throughout China and in specific provinces. Frontiers Media S.A. 2022-06-03 /pmc/articles/PMC9215345/ /pubmed/35757649 http://dx.doi.org/10.3389/fpubh.2022.859499 Text en Copyright © 2022 Yin, Wu, Wang, Luo, Ouyang, Tang, Liu, Liu, Qi, Zhou and Lai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Yin, Peng Wu, Jiayuan Wang, Lijun Luo, Chaole Ouyang, Lihuan Tang, Xiantong Liu, Jiangmei Liu, Yunning Qi, Jinlei Zhou, Maigeng Lai, Tianwen The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 |
title | The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 |
title_full | The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 |
title_fullStr | The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 |
title_full_unstemmed | The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 |
title_short | The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019 |
title_sort | burden of copd in china and its provinces: findings from the global burden of disease study 2019 |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215345/ https://www.ncbi.nlm.nih.gov/pubmed/35757649 http://dx.doi.org/10.3389/fpubh.2022.859499 |
work_keys_str_mv | AT yinpeng theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT wujiayuan theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT wanglijun theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT luochaole theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT ouyanglihuan theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT tangxiantong theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT liujiangmei theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT liuyunning theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT qijinlei theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT zhoumaigeng theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT laitianwen theburdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT yinpeng burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT wujiayuan burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT wanglijun burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT luochaole burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT ouyanglihuan burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT tangxiantong burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT liujiangmei burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT liuyunning burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT qijinlei burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT zhoumaigeng burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 AT laitianwen burdenofcopdinchinaanditsprovincesfindingsfromtheglobalburdenofdiseasestudy2019 |